Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03615
Species: Homo sapiens
Position : chr12:6933000-6941000
Year: 2025
Title: LNP-enclosed NamiRNA inhibits pancreatic cancer proliferation and migration via dual pathways.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: pancreatic ductal adenocarcinoma
PMID:  40611281
MONDO: MONDO:0005184
Tissue: pancreas
Tissue Ontology ID: UBERON:0001264
Cell Source: MIA PaCa-2
CVCL ID: CVCL_0428
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, Functional perturbation assay, TF binding assay; In vivo functional validation
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, ChIP-RT-qPCR, qRT-PCR, Western blot; In vivo phenotyping
About Target Gene
Target gene : PTPN6
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer